AIMS installs cobas pro e801 and cobas pure e402 to offer advanced diagnostics and improve patient experience
Asian Institute of Medical Science (AIMS), the premium super-speciality tertiary care hospital in Delhi NCR, has taken a significant leap forward in healthcare delivery by incorporating Roche Diagnostics’ state-of-the-art technology. The installation of cobas pro e801 and cobas pure e402 aims to enhance diagnostics, expand the assay menu, and provide superior patient care.
In today’s healthcare landscape, patients have higher expectations and are increasingly aware of the benefits of medical technology. The COVID-19 pandemic has further emphasized the importance of diagnostics for preventive care and overall health management. Recognizing this shift, AIMS has embraced advanced technology to meet patient demands and ensure their satisfaction. The hospital’s commitment to delivering quality healthcare services has earned it accreditation from NABH and NABL.
During the installation ceremony, attended by esteemed dignitaries including Dr. N K Pandey, Chairman and Managing Director, Dr. Prashant Pandey, Director – Medical Services, Mr. Anupam Pandey, Director Administration, and Dr. Uma Rani, HOD, Laboratory Medicine, the potential of the cobas pro e801 and cobas pure e402 technologies was highlighted.
Dr. Uma Rani, HOD, Laboratory Medicine, expressed her enthusiasm for the new diagnostics solutions, stating, “Diagnostics play a crucial role in disease management, and at AIMS, we are dedicated to providing personalized patient care. The installation of cobas pro e801 and cobas pure e402 allows us to cater to a larger patient group and address a wide range of diseases. We are delighted to partner with Roche Diagnostics as this collaboration will enhance the accuracy and speed of test results for our patients.”
The adoption of Roche Diagnostics’ cobas solutions enables AIMS to further advance testing capabilities in the fields of endocrinology, immunology, and metabolic diseases. These cutting-edge instruments offer the industry’s smallest sample volume for immunology and significantly reduce the turnaround time (TAT). The automation features of Roche Diagnostics’ solutions streamline workflows, improve laboratory productivity, and ultimately support the delivery of exceptional patient care.
Also Read: Dr. Ambrish Mithal joins MHC as Chairman and Head of Endocrinology and Diabetes – Pan Max